Avastin/Lucentis Update 52: Another Point of View

As you know, I have been writing about Avastin and the Avastin vs. Lucentis controversy since January 2006. There are now over 50 postings on this subject, and an additional 35 or so on various treatments for AMD, including the Comparisons of Age-Related Macular Degeneration Treatments Trials (the CATT Study). From time to time, as I’ve run across articles or blogs by others pertinent to these subjects, I’ve gotten in touch with the authors and requested permission to reproduce their words here. This is such an instance.

I recently was referred to a blog posting by Laura Newman on (Read more...)

Full Story →